Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
The Lancet. Oncology|May 14, 2018
NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trialVanesa Gregorc, Rabab M Gaafar, Adolfo Favaretto, et al.
International Journal of Molecular Sciences|April 17, 2025
Growth Hormone-Releasing Hormone Antagonists Increase Radiosensitivity in Non-Small Cell Lung Cancer CellsIacopo Gesmundo, Francesca Pedrolli, Francesca Romana Giglioli, et al.
Cancers|August 10, 2024
From Tumor Macroenvironment to Tumor Microenvironment: The Prognostic Role of the Immune System in Oral and Lung Squamous Cell CarcinomaRosa Alessia Battista, Giacomo Maria Pini, Alex Finco, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2009
Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumoursVanesa Gregorc, Giovanni Citterio, Giordano Vitali, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2011
Phase I study of NGR-hTNF, a selective vascular targeting agent, in combination with cisplatin in refractory solid tumorsVanesa Gregorc, Filippo G De Braud, Tommaso M De Pas, et al.
Tropical Medicine and Infectious Disease|June 27, 2023
Strongyloides spp. and Cytomegalovirus Co-Infection in Patient Affected by Non-Hodgkin LymphomaTommaso Lupia, Elena Crisà, Alberto Gaviraghi, et al.
Tropical Medicine and Infectious Disease|July 28, 2023
Overlapping Infection by Strongyloides spp. and Cytomegalovirus in the Immunocompromised Host: A Comprehensive Review of the LiteratureTommaso Lupia, Elena Crisà, Alberto Gaviraghi, et al.
Journal of the National Cancer Institute|May 5, 2005
Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancerFederico Cappuzzo, Fred R Hirsch, Elisa Rossi, et al.
Future Oncology (London, England)|November 15, 2017
Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancerGiulio Metro, Antonio Passaro, Giuseppe Lo Russo, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 16, 2022
Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against CancerGennaro Ciliberto, Marco Canfora, Irene Terrenato, et al.
Pageof 10